Yellow fever cases in Asia: primed for an epidemic

ProMED. Yellow fever—Africa (02): Angola (Luanda) request for information: International Society for Infectious Diseases. ProMED-mail; 2016. Available at: http://www.promedmail.org/post/3958601 (accessed April 11, 2016). ProMED. Yellow fever—Africa (05): Angola (Huila): International Society for Infectious Diseases. ProMED-mail; 2016. Available at: http://www.promedmail.org/post/3977685 (accessed April 11, 2016). World Health Organization. Yellow fever—Democratic Republic of the Congo, 11 April 2016. Geneva: WHO; 2016. Available at: http://www.who.int/csr/don/11-april-2016-yellow-fever-drc/en/ (accessed April 20, 2016). World Health Organization. Yellow Fever—Kenya, 6 April 2016. Geneva: WHO; 2016. Available at: http://www.who.int/csr/don/6-april-2016-yellow-fever-kenya/en/ (accessed April 20, 2016). Lai, 2015, The changing epidemiology of dengue in China, 1990–2014: a descriptive analysis of 25 years of nationwide surveillance data, BMC Med, 13, 100, 10.1186/s12916-015-0336-1 Monath, 2001, Yellow fever: an update, Lancet Infect Dis, 1, 11, 10.1016/S1473-3099(01)00016-0 2009 Carrington, 2013, Evolutionary and ecological factors underlying the tempo and distribution of yellow fever virus activity, Infect Genet Evol, 13, 198, 10.1016/j.meegid.2012.08.015 Cathey, 2014, Yellow fever, Asia and the East African slave trade, Trans R Soc Trop Med Hyg, 108, 252, 10.1093/trstmh/tru043 Bryant, 2007, Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas, PLoS Pathog, 3, e75, 10.1371/journal.ppat.0030075 Tabachnick, 1991, Evolutionary genetics and arthropod-borne disease: the yellow fever mosquito, American Entomologist, 37, 14, 10.1093/ae/37.1.14 Rogers, 2006, The global distribution of yellow fever and dengue, Adv Parasitol, 62, 181, 10.1016/S0065-308X(05)62006-4 Reiter, 2010, Yellow fever and dengue: a threat to Europe, Euro Surveill, 15, 19509, 10.2807/ese.15.10.19509-en Gubler, 2004, The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?, Comp Immunol Microbiol Infect Dis, 27, 319, 10.1016/j.cimid.2004.03.013 Soper, 1963, The elimination of urban yellow fever in the Americas through the eradication of Aedes aegypti, Am J Public Health Nations Health, 53, 7, 10.2105/AJPH.53.1.7 Gubler, 1998, Resurgent vector-borne diseases as a global health problem, Emerg Infect Dis, 4, 442, 10.3201/eid0403.980326 Robertson, 1996, Yellow fever: a decade of reemergence, JAMA, 276, 1157, 10.1001/jama.1996.03540140045025 Pan American Health Organization. Technical Report: Recommendations for scientific evidence-based yellow fever risk assessment in the Americas. PAHO; 2013. Available at: http://www.paho.org/hq/index.php?option=com_docman&task=doc_download&Itemid=270&gid=30613&lang=en (accessed April 11, 2016). Monath, 1991, Yellow fever: Victor, Victoria? Conqueror, conquest? Epidemics and research in the last forty years and prospects for the future, Am J Trop Med Hyg, 45, 1, 10.4269/ajtmh.1991.45.1 Nasidi, 1993, Yellow fever vaccination and pregnancy: a four-year prospective study, Trans R Soc Trop Med Hyg, 87, 337, 10.1016/0035-9203(93)90156-K Garske, 2014, Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data, PLoS Med, 11, e1001638, 10.1371/journal.pmed.1001638 Monath, 2006, Yellow fever as an endemic/epidemic disease and priorities for vaccination, Bull Soc Pathol Exot, 99, 341 World Health Organization. Global and regional immunization profile: African region. Geneva: WHO; 2015. Available at: http://www.who.int/immunization/monitoring_surveillance/data/gs_afrprofile.pdf?ua=1 (accessed April 12, 2016). Massad, 2001, The risk of yellow fever in a dengue-infested area, Trans R Soc Trop Med Hyg, 95, 370, 10.1016/S0035-9203(01)90184-1 Monath, 1999, Facing up to re-emergence of urban yellow fever, Lancet, 353, 1541, 10.1016/S0140-6736(99)00155-5 Barrett, 2007, Yellow fever: a disease that has yet to be conquered, Ann Rev Entomol, 52, 209, 10.1146/annurev.ento.52.110405.091454 Van der Stuyft, 1999, Urbanisation of yellow fever in Santa Cruz, Bolivia. Lancet, 353, 1558, 10.1016/S0140-6736(99)03291-2 2008, Outbreak news. Yellow fever, Paraguay, Wkly Epidemiol Rec, 83, 105 Johansson, 2012, Assessing the risk of international spread of yellow fever virus: a mathematical analysis of an urban outbreak in Asuncion, 2008, Am J Trop Med Hyg, 86, 349, 10.4269/ajtmh.2012.11-0432 Sanders, 1998, First recorded outbreak of yellow fever in Kenya, 1992–1993. I. Epidemiologic investigations, Am J Trop Med Hyg, 59, 644, 10.4269/ajtmh.1998.59.644 Tomori, 2004, Yellow fever: the recurring plague, Crit Rev Clin Lab Sci, 41, 391, 10.1080/10408360490497474 Mutebi, 2002, The epidemiology of yellow fever in Africa, Microbes Infect, 4, 1459, 10.1016/S1286-4579(02)00028-X Powell, 2013, History of domestication and spread of Aedes aegypti—a review, Mem Inst Oswaldo Cruz, 108 Suppl 1, 11, 10.1590/0074-0276130395 Beaty, 1979, In vitro transmission of yellow fever virus by geographic strains of Aedes aegypti, Mosquito News, 39, 232 Mahaffy, 1941, The isolation of yellow fever virus in the Anglo-Egyptian Sudan, Ann Trop Med Parasit, 35, 141, 10.1080/00034983.1941.11685118 Serie, 1968, [Studies on yellow fever in Ethiopia. 6. Epidemiologic study], Bull World Health Organ, 38, 879 Gubler, 2002, The global emergence/resurgence of arboviral diseases as public health problems, Arch Med Res, 33, 330, 10.1016/S0188-4409(02)00378-8 Abrão, 2006, Yellow fever virus interferes with dengue-2 replication and might prevent reurbanization of yellow fever. XVII National Meeting of Virology, Campos do Jordão, SP, Virus Rev Res, 2006, 130 Abrão E, Fonseca B. Viral interference among flaviviruses: the case of dengue-2 and yellow fever viruses. 26th Annual Meeting of The American Society for Virology; 2007, p. 273. Theiler, 1975, The relative resistance of dengue-immune monkeys to yellow fever virus, Am J Trop Med Hyg, 24, 115, 10.4269/ajtmh.1975.24.115 Xiao, 2003, Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses, Am J Trop Med Hyg, 68, 695, 10.4269/ajtmh.2003.68.695 Amaku, 2011, Why dengue and yellow fever coexist in some areas of the world and not in others?, Bio Systems, 106, 111, 10.1016/j.biosystems.2011.07.004 Mutebi, 2001, Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa, J Virol, 75, 6999, 10.1128/JVI.75.15.6999-7008.2001 Black, 2002, Flavivirus susceptibility in Aedes aegypti, Arch Med Res, 33, 379, 10.1016/S0188-4409(02)00373-9 Burt, 2012, Chikungunya: a re-emerging virus, Lancet, 379, 662, 10.1016/S0140-6736(11)60281-X Arankalle, 2007, Genetic divergence of chikungunya viruses in India (1963–2006) with special reference to the 2005–2006 explosive epidemic, J Gen Virol, 88, 1967, 10.1099/vir.0.82714-0 Petersen, 2016, Zika virus, N Engl J Med, 374, 1552, 10.1056/NEJMra1602113 Petersen, 2016, Rapid spread of Zika virus in the Americas—implications for public health preparedness for mass gatherings at the 2016 Brazil Olympic Games, Int J Infect Dis, 44, 11, 10.1016/j.ijid.2016.02.001 IATA press release: Airlines to welcome 3.6 billion passengers in 2016. IATA; 2012. Available at: http://www.iata.org/pressroom/pr/pages/2012-12-06-01.aspx (accessed April 15, 2016). Miller, 1989, Epidemic yellow fever caused by an incompetent mosquito vector, Trop Med Parasitol, 40, 396 Monath, 2002, Prevention of yellow fever in persons traveling to the tropics, Clin Infect Dis, 34, 1369, 10.1086/340104 Kraemer, 2015, The global distribution of the arbovirus vectors Aedes aegypti and Ae, albopictus. eLife, 4, e08347, 10.7554/eLife.08347 Jentes, 2011, The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Gr oup on Geographic Risk for Yellow Fever, Lancet Infect Dis, 11, 622, 10.1016/S1473-3099(11)70147-5 HealthMap. Available at: http://www.healthmap.org/promed/ (accessed April 27, 2016). FLIRT. Available at: http://flirt.eha.io/ (accessed April 27, 2016). 2014 Bres, 1986, A century of progress in combating yellow fever, Bull World Health Organ, 64, 775 Tomori, 2002, Yellow fever in Africa: public health impact and prospects for control in the 21st century, Biomedica, 22, 178 Morrison, 2008, Defining challenges and proposing solutions for control of the virus vector Aedes aegypti, PLoS Med, 5, e68, 10.1371/journal.pmed.0050068 2008 Martins, 2013, 17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study, Hum Vaccin Immunother, 9, 879, 10.4161/hv.22982 Monath, 2016, Yellow fever vaccine supply: a possible solution, Lancet, 387, 1599, 10.1016/S0140-6736(16)30195-7 Lim, 2013, Schistosoma haematobium in China, ex-Africa: new populations at risk?, J Travel Med, 20, 211, 10.1111/jtm.12031